| Autor: |
Yu, Seung Eun, Chung, Seyong, Ha, Hyun‐Su, Kim, Dae‐Hyun, Baek, Sewoom, Kim, Tae Young, Lee, Songhyun, Yoon, Hyo‐Jin, Chung, Soon Won, Lee, Jung Bok, Shin, Young Min, Kim, Hye‐Seon, Kim, Si Young, Park, Joon‐Sang, Kim, Chang‐Soo, Sung, Hak‐Joon |
| Předmět: |
|
| Zdroj: |
Advanced Functional Materials; 4/11/2022, Vol. 32 Issue 15, p1-13, 13p |
| Abstrakt: |
Navigation of nanoparticles to target sites of blood flow disturbance markedly upgrades the diagnostic paradigm in vascular medicine. The theranostic treatment of pre‐stenotic vessels can prevent the irreversible occlusion process effectively. Here, these nanotheranostic functions are established by displaying CDK9(cyclin‐dependent kinase 9)‐targeting peptide (P.) onto nanovesicles (NV) and liposomes using the navigation function and subsequent binding‐on signaling of P. as a game‐changer. When rabbit vessels are allografted with injecting contrast‐loaded P. liposomes, the case‐dependent stenotic degree after 2–6 weeks can be diagnosed accurately within 2–4 days via computed tomography imaging with cross‐validation in a mouse model of partial carotid ligation. Furthermore, the anti‐CDK9 signaling of P. NV is activated post‐targeting and effectively prevents vascular stenosis by suppressing inflammation and lipotoxicity in the vessels, serum, and/or liver. CDK9 targeting is confirmed using computer, in vitro, and in vivo models. This study demonstrates an unprecedented nanotheranostic function for future clinical applications. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text